NPC at ISPOR 2026

Monday | 12:15 – 1:15 PM 

Measuring What Matters: Broader Value Elements in HTA and Their Impact on Access

NPC Chief Science Officer Jon Campbell will join Graham Cookson of the Office of Health Economics, Oriol de Sola-Morales of Fundacio HiTT, Lotte Steuten of the Office of Health Economics, and Jon Tosh of ViiV Healthcare for an educational symposium on “Measuring What Matters: Broader Value Elements in HTA and Their Impact on Access.”

Monday | 1:45 – 2:45 PM 

Economic Evaluations and Value Considerations in ACIP Routine Vaccine Recommendations: A Comprehensive Review

NPC Director of Research Tyler Wagner will share insights from his team’s study on “Economic Evaluations and Value Considerations in ACIP Routine Vaccine Recommendations: A Comprehensive Review” during a featured research podium presentation.

Monday | 3:15 – 4:15 PM 

MFN Meets IRP: How US Pricing Reform Reshapes Global Market Interdependencies

NPC Chief Science Officer Jon Campbell will join Casper Paardekooper and David Ringger of Cencora, Scott Greig of Sanofi, and Indranil Bagchi of GSK for an educational symposium on “MFN Meets IRP: How US Pricing Reform Reshapes Global Market Interdependencies.”

Monday | 6:00 – 7:00 PM 

Poster Session

• NPC Senior Director of Research Yevgeniy Feyman will present findings from new NPC research on the “Association of Plan Characteristics and HIV Outcomes With PrEP Therapy Access on Commercial Formularies.”
   
• NPC Vice President of Research and Director of the NPC Enterprise Lab Julie Patterson will share the results of NPC research on “Early Patterns in Second Orphan Drug Designations Following Expansion of the Orphan Drug Exclusion.”
   
• Former NPC Summer Scholar Kanya Shah of the University of Illinois Chicago will present NPC research on “Generic Entry and the Early Impact on U.S. Pharmaceutical Spending.”

Tuesday, May 19 | 10:30 – 11:30 AM

Are Drug Prices Rising Too Fast? Rethinking Inflation Benchmarks Through the Lens of Value, Access, and Innovation

NPC Chief Science Officer Jon Campbell will join Laura Pizzi of ISPOR, Andrew York of the Maryland Prescription Drug Affordability Board, and moderator William Padula of the University of Southern California for an issue panel titled “Are Drug Prices Rising Too Fast? Rethinking Inflation Benchmarks Through the Lens of Value, Access, and Innovation.”

Tuesday, May 19 | 4:45 – 5:45 PM 

Can New Approaches to Estimating Dynamic Efficiency Help to Maintain Both Access and Innovation in Pharmaceutical Markets?

Dr. Patterson will join Anirban Basu of the University of Washington, Robert B. McQueen of the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and moderator Robert J. Nordyke of Beta6 Consulting for an issue panel exploring “Can New Approaches to Estimating Dynamic Efficiency Help to Maintain Both Access and Innovation in Pharmaceutical Markets?” 

Tuesday | 6:00 – 7:00 PM ET

Poster Session

• NPC Associate Director of Research Hanke Zheng will share NPC research on “Exploring the Potential Impact of the Inflation Reduction Act’s Part D Redesign on Formulary Coverage in Competitive Classes: 2024-2026.”
   
• At the same time, William Canestaro of the University of Washington will present findings on “The Potential Early Impact of the Inflation Reduction Act on Buy-Side Valuation Methodologies and Transaction Structuring in the Pharmaceutical Industry” — research produced in partnership with NPC.

Wednesday | 9:00 – 10:00 AM ET

Poster Session

Dr. Zheng will provide an overview of the “Clinical Development Landscape and Characteristics of Rare Diseases in the U.S.” as explored in new research from NPC.

Wednesday, May 20 | 10:00 – 11:00 AM ET

From Debate to Dialogue: Building Consensus on Prior Authorization Reform

Ms. Westrich will moderate a conversation between James Chambers of Tufts Medical Center, Anna Hyde of the Arthritis Foundation, and John Watkins of the University of Washington on “From Debate to Dialogue: Building Consensus on Prior Authorization Reform.”